Atreca, Inc. - (BCEL) Social Stream



Atreca, Inc. - (BCEL): $0.09

0.01 (+6.25%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add BCEL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#124 of 390

in industry

ATRECA INC (BCEL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ATRECA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-31 7 $30 $12 $21.333 $0.115 18450.43%
2022-02-04 5 $27 $11 $18.166 $0.115 15696.52%
2022-03-04 7 $27 $11 $18.166 $0.115 15696.52%
2022-05-13 7 $25 $11 $16.833 $0.115 14537.39%
2022-06-02 6 $25 $9 $15.714 $0.115 13564.35%
2022-08-09 7 $25 $9 $14.714 $0.115 12694.78%
2022-11-11 6 $25 $9 $14 $0.115 12073.91%
2022-11-15 6 $25 $4 $12.666 $0.115 10913.91%
2023-01-05 7 $25 $4 $12.285 $0.115 10582.61%
2023-02-07 6 $25 $4 $11.857 $0.115 10210.43%
2023-03-30 8 $25 $1.5 $10.187 $0.115 8758.26%
2023-05-11 8 $25 $1.5 $9.062 $0.115 7780%
2023-06-05 8 $25 $1.5 $9.071 $0.115 7787.83%
2023-08-11 5 $9 $1 $5 $0.115 4247.83%
2023-08-14 7 $10 $1 $5.25 $0.115 4465.22%

The Trend in the Analyst Price Target


BCEL's average price target has moved down $17.5 over the prior 25 months.

Over the past 29 weeks, BCEL's average upside potential has been 805.25%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-07 7 25 4.0 11.857 1.660 614.28%
2023-05-11 8 25 1.5 9.062 0.954 849.9%
2023-08-14 7 10 1.0 5.250 0.510 929.41%
2023-08-14 8 10 1.0 4.500 0.510 782.35%
2023-08-14 7 10 1.0 4.500 0.510 782.35%

BCEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.25 3 0 5 0 0 8

The Trend in the Broker Recommendations


BCEL's average broker recommendation rating worsened by 0.97 over the prior 41 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, ATRECA INC's upside potential (average analyst target price relative to current price) is higher than 2695.96% of them.
  • In the context of all US stocks, ATRECA INC's variance in analysts' estimates is lower than -2428.44% of them.
  • In the context of Healthcare stocks, ATRECA INC's average analyst price target is greater than 571.82% of them.
  • ATRECA INC's number of analysts covering the stock is greater than 2087.33% of stocks in the small market cap category.

In the Pharmaceutical Products industry, ENSC, NRXP, and NCNA are the three stocks most similar to ATRECA INC regarding the price target and analyst recommendation information presented here.

What is the outlook for BCEL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!